MEF2C has been implicated in multiple neuropsychiatric phenotypes and disorders, including autism spectrum disorder, schizophrenia, and Alzheimer’s disease (35–39). This evidence concerns the gene MEF2C and early-onset autosomal dominant Alzheimer disease.